These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33767986)

  • 21. Role of miR
    Liu Y; Hu Q; Ao J; Li H; Li M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):280-289. PubMed ID: 32386020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1.
    Lv T; Song K; Zhang L; Li W; Chen Y; Diao Y; Yao Q; Liu P
    Biochem Cell Biol; 2018 Oct; 96(5):663-671. PubMed ID: 29561664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-575 regulates development of gastric cancer by targeting PTEN.
    Wang YN; Xu F; Zhang P; Wang P; Wei YN; Wu C; Cheng SJ
    Biomed Pharmacother; 2019 May; 113():108716. PubMed ID: 30844657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
    Lin M; Xia B; Qin L; Chen H; Lou G
    DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells.
    Chen W; Huang L; Hao C; Zeng W; Luo X; Li X; Zhou L; Jiang S; Chen Z; He Y
    Tumour Biol; 2016 Jul; 37(7):9289-99. PubMed ID: 26779627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
    Li X; Chen W; Zeng W; Wan C; Duan S; Jiang S
    Br J Cancer; 2017 Jan; 116(1):66-76. PubMed ID: 27875524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-186 bidirectionally regulates cisplatin sensitivity of ovarian cancer cells via suppressing targets PIK3R3 and PTEN and upregulating APAF1 expression.
    Xiang Y; Chen YJ; Yan YB; Liu Y; Qiu J; Tan RQ; Tian Q; Guan L; Niu SS; Xin HW
    J Cancer; 2020; 11(12):3446-3453. PubMed ID: 32284740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85.
    Wu D; Lu P; Mi X; Miao J
    Arch Gynecol Obstet; 2018 Mar; 297(3):699-707. PubMed ID: 29327155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.
    Yoneyama K; Ishibashi O; Kawase R; Kurose K; Takeshita T
    Anticancer Res; 2015 Mar; 35(3):1401-10. PubMed ID: 25750291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.
    Liu Y; Niu Z; Lin X; Tian Y
    Cancer Gene Ther; 2017 May; 24(5):208-214. PubMed ID: 28281524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance.
    Yang L; Li N; Wang H; Jia X; Wang X; Luo J
    Oncol Rep; 2012 Aug; 28(2):592-600. PubMed ID: 22614869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway.
    Lu C; Wang H; Chen S; Yang R; Li H; Zhang G
    J Cell Mol Med; 2018 Apr; 22(4):2478-2487. PubMed ID: 29392841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.
    Báez-Vega PM; Echevarría Vargas IM; Valiyeva F; Encarnación-Rosado J; Roman A; Flores J; Marcos-Martínez MJ; Vivas-Mejía PE
    Oncotarget; 2016 Jun; 7(24):36321-36337. PubMed ID: 27166999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells.
    Fu X; Tian J; Zhang L; Chen Y; Hao Q
    FEBS Lett; 2012 May; 586(9):1279-86. PubMed ID: 22465665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-509-3p enhances platinum drug sensitivity in ovarian cancer.
    Niu L; Ni H; Hou Y; Du Q; Li H
    Gene; 2019 Feb; 686():63-67. PubMed ID: 30408550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells.
    Samuel P; Pink RC; Caley DP; Currie JM; Brooks SA; Carter DR
    Tumour Biol; 2016 Feb; 37(2):2565-73. PubMed ID: 26386726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8.
    Cui Y; Wu F; Tian D; Wang T; Lu T; Huang X; Zhang P; Qin L
    Oncol Rep; 2018 Apr; 39(4):1649-1657. PubMed ID: 29436681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-Tetrahydropalmatine enhances the sensitivity of human ovarian cancer cells to cisplatin via microRNA-93/PTEN/Akt cascade.
    Gong J; Xing C; Wang LY; Xie SS; Xiong WD
    J BUON; 2019; 24(2):701-708. PubMed ID: 31128026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.